How to choose core outcome measurement sets for clinical trials: OMERACT 11 approves filter 2.0.

@article{Boers2014HowTC,
  title={How to choose core outcome measurement sets for clinical trials: OMERACT 11 approves filter 2.0.},
  author={Maarten Boers and John R Kirwan and Laure Gossec and Philip G Conaghan and Maria-Antonietta D'Agostino and Clifton O Bingham and Peter M Brooks and Robert B. M. Landew{\'e} and Lyn March and L. Sobita Simon and Jasvinder A Singh and Vibeke Strand and George A Wells and Peter Tugwell},
  journal={The Journal of rheumatology},
  year={2014},
  volume={41 5},
  pages={1025-30}
}
OBJECTIVE The Outcome Measures in Rheumatology (OMERACT) initiative works to develop core sets of outcome measures for trials and observational studies in rheumatology. At the OMERACT 11 meeting, substantial time was devoted to discussing a conceptual framework and a proposal for a more explicit working process to develop what we now propose to term core… CONTINUE READING